Terms: = Liver cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Clinical Outcome
50 results:
1. COP9 signalosome complex is a prognostic biomarker and corresponds with immune infiltration in hepatocellular carcinoma.
Liu J; Han D; Xuan J; Xie J; Wang W; Zhou Q; Chen K
Aging (Albany NY); 2024 Mar; 16(6):5264-5287. PubMed ID: 38466642
[TBL] [Abstract] [Full Text] [Related]
2. Spatial resolution of cellular senescence dynamics in human colorectal liver metastasis.
Garbarino O; Lambroia L; Basso G; Marrella V; Franceschini B; Soldani C; Pasqualini F; Giuliano D; Costa G; Peano C; Barbarossa D; Annarita D; Salvati A; Terracciano L; Torzilli G; Donadon M; Faggioli F
Aging Cell; 2023 Jul; 22(7):e13853. PubMed ID: 37157887
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive analysis of cell death genes in hepatocellular carcinoma based on multi-omics data.
Zhang L; Chen X; Guo X; Shen H; Qiu D; Jin W; Hou D
Adv Clin Exp Med; 2023 Feb; 32(2):233-244. PubMed ID: 36753369
[TBL] [Abstract] [Full Text] [Related]
4. Elevated expression of the MYB proto-oncogene like 2 (MYBL2)-encoding gene as a prognostic and predictive biomarker in human cancers.
Xin Z; Li Y; Meng L; Dong L; Ren J; Men J
Math Biosci Eng; 2022 Jan; 19(2):1825-1842. PubMed ID: 35135230
[TBL] [Abstract] [Full Text] [Related]
5. Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the clinical outcome in Hepatocellular Carcinoma.
Tang X; Miao Y; Wang J; Cai T; Yang L; Mi D
Comput Math Methods Med; 2021; 2021():1205029. PubMed ID: 34840594
[TBL] [Abstract] [Full Text] [Related]
6. Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib.
Fujii Y; Ono A; Hayes CN; Aikata H; Yamauchi M; Uchikawa S; Kodama K; Teraoka Y; Fujino H; Nakahara T; Murakami E; Miki D; Okamoto W; Kawaoka T; Tsuge M; Imamura M; Chayama K
J Exp Clin Cancer Res; 2021 Jun; 40(1):215. PubMed ID: 34174931
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive functional genomic analyses link APC somatic mutation and mRNA-miRNA networks to the clinical outcome of stage-III colorectal cancer patients.
Chiang SF; Huang HH; Tsai WS; Chin-Ming Tan B; Yang CY; Huang PJ; Yi-Feng Chang I; Lin J; Lu PS; Chin E; Liu YH; Yu JS; Chiang JM; Hung HY; You JF; Liu H
Biomed J; 2022 Apr; 45(2):347-360. PubMed ID: 35550340
[TBL] [Abstract] [Full Text] [Related]
8. TMEM166 inhibits cell proliferation, migration and invasion in hepatocellular carcinoma via upregulating tp53.
Yang J; Wang B; Xu Q; Yang Y; Hou L; Yin K; Guo Q; Hua Y; Zhang L; Li Y; Zhang J; Li N
Mol Cell Biochem; 2021 Feb; 476(2):1151-1163. PubMed ID: 33200377
[TBL] [Abstract] [Full Text] [Related]
9. Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis repeat-containing 5 in tp53-mutated hepatocellular carcinoma.
Li Y; Zhao ZG; Luo Y; Cui H; Wang HY; Jia YF; Gao YT
World J Gastroenterol; 2020 Aug; 26(32):4786-4801. PubMed ID: 32921957
[TBL] [Abstract] [Full Text] [Related]
10. Low
Yim SY; Kang SH; Shin JH; Jeong YS; Sohn BH; Um SH; Lee JS
Cells; 2020 Sep; 9(9):. PubMed ID: 32878261
[TBL] [Abstract] [Full Text] [Related]
11. Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions.
Hilmi M; Neuzillet C; Calderaro J; Lafdil F; Pawlotsky JM; Rousseau B
J Immunother Cancer; 2019 Nov; 7(1):333. PubMed ID: 31783782
[TBL] [Abstract] [Full Text] [Related]
12. Identification of a molecular subtyping system associated with the prognosis of Asian hepatocellular carcinoma patients receiving liver resection.
Ma X; Gu J; Wang K; Zhang X; Bai J; Zhang J; Liu C; Qiu Q; Qu K
Sci Rep; 2019 May; 9(1):7073. PubMed ID: 31068611
[TBL] [Abstract] [Full Text] [Related]
13. Renal Epithelioid Angiomyolipoma Undergoing Aggressive clinical outcome: The MDM2 Expression in Tumor Cells of Two Cases.
Inoue C; Saito R; Nakanishi W; Kumata H; Eba S; Fujishima F; Watanabe M; Sasano H
Tohoku J Exp Med; 2019 Feb; 247(2):119-127. PubMed ID: 30799331
[TBL] [Abstract] [Full Text] [Related]
14. SOX9 expression decreases survival of patients with intrahepatic cholangiocarcinoma by conferring chemoresistance.
Yuan X; Li J; Coulouarn C; Lin T; Sulpice L; Bergeat D; De La Torre C; Liebe R; Gretz N; Ebert MPA; Dooley S; Weng HL
Br J Cancer; 2018 Nov; 119(11):1358-1366. PubMed ID: 30420613
[TBL] [Abstract] [Full Text] [Related]
15. Molecular genomic landscapes of hepatobiliary cancer.
Shibata T; Arai Y; Totoki Y
Cancer Sci; 2018 May; 109(5):1282-1291. PubMed ID: 29573058
[TBL] [Abstract] [Full Text] [Related]
16. Tumor Heterogeneity Predicts Metastatic Potential in Colorectal cancer.
Joung JG; Oh BY; Hong HK; Al-Khalidi H; Al-Alem F; Lee HO; Bae JS; Kim J; Cha HU; Alotaibi M; Cho YB; Hassanain M; Park WY; Lee WY
Clin Cancer Res; 2017 Dec; 23(23):7209-7216. PubMed ID: 28939741
[No Abstract] [Full Text] [Related]
17. Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer.
Suenaga M; Schirripa M; Cao S; Zhang W; Yang D; Murgioni S; Rossini D; Marmorino F; Mennitto A; Ning Y; Okazaki S; Berger MD; Miyamoto Y; Gopez R; Barzi A; Yamaguchi T; Loupakis F; Lenz HJ
Ann Oncol; 2017 May; 28(5):1015-1022. PubMed ID: 28453695
[TBL] [Abstract] [Full Text] [Related]
18. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
[TBL] [Abstract] [Full Text] [Related]
19. Genomic Profiling of Biliary Tract cancers and Implications for clinical Practice.
Jain A; Kwong LN; Javle M
Curr Treat Options Oncol; 2016 Nov; 17(11):58. PubMed ID: 27658789
[TBL] [Abstract] [Full Text] [Related]
20. EGFR and SYNE2 are associated with p21 expression and SYNE2 variants predict post-operative clinical outcomes in HBV-related hepatocellular carcinoma.
Han C; Liao X; Qin W; Yu L; Liu X; Chen G; Liu Z; Lu S; Chen Z; Su H; Zhu G; Lu Z; Liu Z; Qin X; Gui Y; Mo Z; Li L; Peng T
Sci Rep; 2016 Aug; 6():31237. PubMed ID: 27502069
[TBL] [Abstract] [Full Text] [Related]
[Next]
